On 27 April 2026, a significant legal battle unfolded at the US Supreme Court, as the justices deliberated on the contentious issue of glyphosate, a herbicide found in the widely used Roundup product. The case, formally known as Monsanto v Durnell, has sparked intense debate over consumer rights and the regulation of pesticides, particularly in light of numerous studies linking glyphosate to cancer. With over 100,000 lawsuits already filed against Bayer, which acquired Monsanto, the outcome of this case could shape the future landscape of pesticide regulation and consumer protections across the nation.
The Legal Landscape of Glyphosate
At the heart of the case is glyphosate, a chemical that has been classified as a probable human carcinogen by the World Health Organization since 2015. Bayer, which inherited the legal woes of Monsanto, has faced an avalanche of litigation from individuals claiming that exposure to glyphosate has resulted in non-Hodgkin lymphoma. The company argues that it has been transparent in its product warnings, contending that it cannot be held liable for failing to issue cancer warnings unless the Environmental Protection Agency (EPA) has mandated such warnings.
During the hearing, the justices posed probing questions to lawyers representing Monsanto, seeking clarity on whether federal law, specifically the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), preempts state-level lawsuits. The crux of the argument hinges on whether states can permit claims against pesticide manufacturers when the EPA has not recognised a cancer risk.
Arguments from Both Sides
Paul Clement, representing Monsanto, maintained that FIFRA’s provisions prohibit pesticide manufacturers from altering product warnings without EPA approval. He emphasised the importance of regulatory uniformity, suggesting that allowing states to impose additional warnings could destabilise the agricultural sector, which relies on federal guidelines. “Ignoring Congress’ clear direction here would open the door for crippling liability,” Clement stated, reinforcing the need for consistency in pesticide regulation.
Conversely, attorney Ashley Keller argued that FIFRA does not grant the sweeping immunity claimed by Monsanto. He pointed out significant flaws in the EPA’s registration process, asserting that the agency has not adhered to legal mandates for timely reviews of glyphosate’s safety. Keller highlighted that the Ninth Circuit Court of Appeals had previously vacated the EPA’s findings regarding glyphosate due to procedural missteps.
The justices’ inquiries reflected a deep engagement with the implications of the arguments presented. Some justices questioned how new scientific evidence should influence existing product labels, while others pondered the fairness of penalising companies for warnings approved by the EPA.
Public Response and Protests
Outside the Supreme Court, a passionate crowd rallied in support of consumers, voicing their concerns over the influence of pesticide manufacturers on public health. Protesters, organised by the Maha movement, expressed their frustration with the Trump administration’s backing of Monsanto’s position. Signs bearing slogans such as “Roundup the guilty” and “Make Monsanto pay” highlighted the collective demand for accountability.
Zen Honeycutt, founder of Moms Across America, articulated the urgency of the moment. “It’s crucial right now to show up and let not just the Supreme Court know but also our legislative branch and our executive branch that we will not stand for being poisoned,” she declared. Independent toxicologist Alexandra Munoz echoed this sentiment, stating unequivocally, “The evidence is really clear” regarding glyphosate’s carcinogenic potential.
Among the protestors was Chellie Pingree, a Democratic representative from Maine, who expressed optimism about the bipartisan support for consumer protections against harmful chemicals. “To have so many people show up from all over the country… it’s a big day,” she remarked.
A Pivotal Moment for Consumer Rights
As the Supreme Court prepares to deliver its ruling, expected this summer, the implications of this case extend far beyond glyphosate. It represents a crucial intersection of science, law, and public health, with the potential to redefine the boundaries of consumer rights in the face of corporate power. The outcome could either reinforce the regulatory framework that governs pesticide safety or embolden manufacturers to sidestep accountability for health risks associated with their products.
Why it Matters
The decision in Monsanto v Durnell will resonate across the United States, impacting not only the future of glyphosate and other pesticides but also the broader landscape of consumer protection laws. A ruling in favour of Monsanto could set a dangerous precedent, limiting consumers’ ability to hold companies accountable for health risks, while a decision supporting state-level lawsuits may empower individuals seeking justice against powerful corporations. As the stakes rise, the public’s call for transparency and accountability in the face of potential health threats is more crucial than ever.
